Skip to Main Content

Author Details

Juan L Callejas-Valera
Cancer Biology Research Center
2008
23
15
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35626103Characterization of the Immune Response to PD-1 Blockade during Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma.Cancers (Basel)2022
32479189Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB Study.J Clin Oncol2020
32848210HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers.Oncogene2020
32436348A PIK3CA transgenic mouse model with chemical carcinogen exposure mimics human oral tongue tumorigenesis.Int J Exp Pathol2020
30187213Correction to: mTOR co-targeting strategies for head and neck cancer therapy.Cancer Metastasis Rev2019
30297705β<sub>2</sub>-Adrenergic receptor modulates mitochondrial metabolism and disease progression in recurrent/metastatic HPV(+) HNSCC.Oncogenesis2018
30045979Transcriptional signature primes human oral mucosa for rapid wound healing.Sci Transl Med2018
29985391Assembly and activation of the Hippo signalome by FAT1 tumor suppressor.Nat Commun2018
28822012mTOR co-targeting strategies for head and neck cancer therapy.Cancer Metastasis Rev2017
28416454E1a is an exogenous in vivo tumour suppressor.Cancer Lett2017
28301547Epidermal loss of Gαq confers a migratory and differentiation defect in keratinocytes.PLoS One2017
26977801MKP1: Jekyll and Hyde for E1A.Aging (Albany NY)2016
27538837mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model.Carcinogenesis2016
26882569A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA+ oral cancers.Oncotarget2016
26689986MKP1 mediates chemosensitizer effects of E1a in response to cisplatin in non-small cell lung carcinoma cells.Oncotarget2015
24196438E1a promotes c-Myc-dependent replicative stress: implications in glioblastoma radiosensitization.Cell Cycle2014
23434069Control of the epithelial stem cell epigenome: the shaping of epithelial stem cell identity.Curr Opin Cell Biol2013
23730213ERK5/BMK1 is a novel target of the tumor suppressor VHL: implication in clear cell renal carcinoma.Neoplasia2013
21841826P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance.Oncogene2012
22164285Balance between MKK6 and MKK3 mediates p38 MAPK associated resistance to cisplatin in NSCLC.PLoS One2011
19568437ERK2, but not ERK1, mediates acquired and "de novo" resistance to imatinib mesylate: implication for CML therapy.PLoS One2009
17893873c-Abl activates p38 MAPK independently of its tyrosine kinase activity: Implications in cisplatin-based therapy.Int J Cancer2008
18316372E1a gene expression blocks the ERK1/2 signaling pathway by promoting nuclear localization and MKP up-regulation: implication in v-H-Ras-induced senescence.J Biol Chem2008
  • 1 - 23 of 23

Recommended Authors

Hua Li
University of California san francisco
Career Start Year 2013
Number of shared co-authors 0
Victor Olivas
University of California san francisco
Career Start Year 2012
Number of shared co-authors 0
Shilpa Bhatia
University of Colorado Denver at Anschutz Medical Campus
Career Start Year 2011
Number of shared co-authors 1
Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 1
Guo Chen
China Pharmaceutical University
Career Start Year 2009
Number of shared co-authors 1
Young K Song
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 1
Stephen B Keysar
University of Colorado Denver
Career Start Year 2006
Number of shared co-authors 1
Neil E Bhola
Zai Lab (US) LLC
Career Start Year 2006
Number of shared co-authors 3
Daniel Schramek
University of Toronto
Career Start Year 2005
Number of shared co-authors 0
Antonio L Amelio
University of North Carolina at Chapel Hill
Career Start Year 2004
Number of shared co-authors 0
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 0
Wei Shi
Research Institute, Princess Margaret Cancer Centre
Career Start Year 2002
Number of shared co-authors 0
Natalia Issaeva
The University of North Carolina at Chapel Hill
Career Start Year 2002
Number of shared co-authors 0
Daniel Zingg
Netherlands Cancer Institute
Career Start Year 2001
Number of shared co-authors 1
Yaoqi Alan Wang
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0
Peter S Hammerman
Novartis Institutes for BioMedical Research
Career Start Year 1996
Number of shared co-authors 2
Mitchell J Frederick
Baylor College of Medicine
Career Start Year 1995
Number of shared co-authors 8
Nabeel Bardeesy
Massachusetts General Hospital
Career Start Year 1992
Number of shared co-authors 1
Qimin Zhan
Peking University Cancer Hospital
Career Start Year 1989
Number of shared co-authors 0
E Alejandro Sweet-Cordero
University of California San Francisco
Career Start Year 1989
Number of shared co-authors 1
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 0
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 0
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 2
Daniel S Peeper
Netherlands Cancer Institute
Career Start Year 1987
Number of shared co-authors 1
Lori S Hart
Children's Hospital of Philadelphia, USA. [2] Center for Childhood Cancer Research
Career Start Year 1987
Number of shared co-authors 0
Wendell G Yarbrough
University of North Carolina at Chapel Hill
Career Start Year 1986
Number of shared co-authors 0
Daniel E Johnson
University of California San Francisco
Career Start Year 1985
Number of shared co-authors 3
Carter Van Waes
National Institute of Deafness and Other Communication Disorders
Career Start Year 1984
Number of shared co-authors 4
Ze'ev Ronai
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1981
Number of shared co-authors 3
Norman E Sharpless
National Cancer Institute
Career Start Year 1945
Number of shared co-authors 0

Collaborators

Jorge Silvio Gutkind
Moores Cancer Center, University of California San Diego
Co-authored papers 12
Alfredo A Molinolo
University of California
Co-authored papers 6
Zhiyong Wang
Moores Cancer Center, University of California San Diego
Co-authored papers 5
Joseph A Califano
University of California
Co-authored papers 3
Ezra E W Cohen
university of california san diego Health System
Co-authored papers 2
Scott M Lippman
Moores Cancer Center, university of california san diego
Co-authored papers 2
Pablo Tamayo
University of California San Diego
Co-authored papers 2
Kathleen M Fisch
Center for Computational Biology and Bioinformatics, University of California
Co-authored papers 1
Shuling Ren
Beijing Friendship Hospital, Capital Medical University
Co-authored papers 1
Guorong Xu
Chinese University of Hong Kong
Co-authored papers 1
Yardena Samuels
Weizmann Institute of Science
Co-authored papers 1
Theresa Guo
Moores Cancer Center, University of California
Co-authored papers 1
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Kun-Liang Guan
University of California San Diego
Co-authored papers 1
Akihiro Sakai
Tokai University
Co-authored papers 1
Michael W Deininger
University of Utah Huntsman Cancer Institute
Co-authored papers 1
Alexander V Favorov
Johns Hopkins School of Medicine
Co-authored papers 1
Chao Liu
Xiangya Hospital, Central South University
Co-authored papers 1
Takahito Fukusumi
Osaka University Graduate School of Medicine
Co-authored papers 1
Mara Gilardi
Institute of Medical Genetics and Pathology.
Co-authored papers 1
Michael M Allevato
University of Michigan Medical School.
Co-authored papers 1
Jessica Santos
Moores Cancer Center, University of California San Diego
Co-authored papers 1
Daria A Gaykalova
Institute for Genome Sciences, University of Maryland School of Medicine
Co-authored papers 1
Mizuo Ando
University of Tokyo
Co-authored papers 1
Wayne M Koch
Johns Hopkins University School of Medicine
Co-authored papers 1
Trey Ideker (CM4AI)
University of California San Diego
Co-authored papers 1
Maudi Killian
University of California San Francisco
Co-authored papers 1
Sayed Sadat
Moores Cancer Center, University of California San Diego
Co-authored papers 1
Toshiro Moroishi
Kumamoto University
Co-authored papers 1
Huwate Yeerna
Moores Cancer Center, University of California
Co-authored papers 1
Release 1.2